Colorcon starts No-Tox ink manufacturing at new UK facility
The additional capacity will provide customers with shorter lead times and reduced transportation costs.
Colorcon No-Tox Products, a leader in the design and manufacture of FDA and EU regulatory compliant specialty printing inks for direct and indirect contact with food, medical devices and pharmaceutical products has opened a new UK-based manufacturing facility to serve its growing customer base in Europe, the Middle East and Africa (EMEA).
With this new manufacturing capacity, Colorcon No-Tox is strengthening its presence in the European and UK markets and will provide its customers with shorter lead times and reduced transportation costs.
“We are excited to announce this important next step in our strategy to become an integral part of our customers’ supply chains,” said Simon Tasker, President, Colorcon Americas.
“Our new No-Tox plant in the UK, which is an extension of our existing pharmaceutical manufacturing plant in Dartford will allow us to serve our customers in increasingly better and more efficient ways by providing our high-quality regulatory compliant inks and coatings with close proximity to their markets and at lower transportation costs.”
David Bain, Managing Director, Colorcon Ltd added: “Our regional team is looking forward to supporting this next stage in the strategic market expansion of our Colorcon No-Tox specialty printing ink business. The plant will initially focus on regulatory compliant inks and coatings for direct and indirect food contact applications; such as those widely used in the plastic to paper straw conversion. The addition of medical and pharmaceutical inks and coatings will be extended through 2020.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance